| Literature DB >> 26017664 |
H Akhloufi1, R H Streefkerk, D C Melles, J E M de Steenwinkel, C A M Schurink, R P Verkooijen, C P van der Hoeven, A Verbon.
Abstract
Antimicrobial stewardship teams have been shown to increase appropriate empirical antibiotic therapy and reduce medical errors and costs in targeted populations, but the effect in non-targeted populations is still unclear. The aim of this study was to determine the prevalence of inappropriate antibiotic use in a large university hospital and identify areas in which antimicrobial stewardship will be the most effective. In a point prevalence survey we assessed the appropriateness of antibiotic therapy using an electronic surveillance system in combination with a standardized method for duration of therapy, dosage, dosage interval, route of administration, and choice of antibiotic drug. Patients using at least one antibiotic drug were included. Among 996 patients admitted in the surveyed wards, 337 patients (33.8 %) used one or more antibiotic drugs. Two hundred and twenty-one patients (22.2 %) used antibiotic medication therapeutically, with a total of 307 antibiotic prescriptions. Antibiotic therapy was deemed inappropriate in 90 (29.3 %) of these prescribed antibiotics, with an unjustified prescription as the most common reason for an inappropriate prescription. Use of fluoroquinolones and amoxicillin/clavulanic acid and a presumed diagnosis of fever of unknown origin, urinary tract infection, and respiratory tract infection were associated with inappropriate antibiotic therapy. Our study provides insight into the (in)appropriateness of antibiotic prescriptions in a tertiary care center in the Netherlands and identifies areas for improvement. The use of an electronic surveillance system for this point prevalence study is easy and may serve as a baseline measurement for the future effect of antibiotic stewardship.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26017664 PMCID: PMC4514905 DOI: 10.1007/s10096-015-2398-6
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
Categories evaluation of the appropriateness of antimicrobial drug therapy (ADT)
| Categories | Absolute frequency | Percentage of total number of prescriptions |
|---|---|---|
| I. Appropriate ADT | 199 | 64.8 |
| II. Inappropriate ADT, due to incorrect use: | 21a | 6.8 |
| a. Improper duration | 10 | 3.3 |
| b. Improper route | 6 | 2.0 |
| c. Improper dosage interval | 10 | 3.3 |
| d. Improper dosage | 8 | 2.6 |
| III. Inappropriate ADT, due to an incorrect choice: | 25a | 8.1 |
| a. Allergy to the prescribed antibiotic drug | 0 | 0 |
| b. Less broad-spectrum alternative agent | 9 | 2.9 |
| c. Less expensive alternative agent | 7 | 2.3 |
| d. Less toxic alternative agent | 4 | 1.3 |
| e. More effective alternative agent | 15 | 4.9 |
| IV. Inappropriate ADT, due to unjustified prescription: use of any antimicrobial is not indicated | 48 | 15.6 |
| V. Insufficient information | 18 | 5.9 |
aFour antibiotic prescriptions were inappropriate due to incorrect use and choice
Appropriateness of antibiotic prescriptions according to the class of antibiotica
| Antimicrobial agent | Number of prescriptions (% of total) | Number of inappropriate prescriptions | Proportion of inappropriate prescriptions (95 % confidence interval) | ORb for inappropriate prescriptions (95 % confidence interval) |
|---|---|---|---|---|
| Fluoroquinolones | 37 (12.1) | 18 | 0.49 (0.33–0.64) | Reference |
| Amoxicillin/clavulanic acid | 34 (11.1) | 15 | 0.44 (0.29–0.61) | 0.88 (0.34–2.29) |
| Meropenem | 28 (9.1) | 5 | 0.18 (0.08–0.36) | 0.24 (0.07–0.77) |
| Cephalosporins, second generation | 27 (8.8) | 10 | 0.37 (0.22–0.56) | 0.63 (0.22–1.74) |
| Piperacillin/tazobactam | 26 (8.5) | 8 | 0.31 (0.17–0.50) | 0.50 (0.17–1.46) |
| Glycopeptides | 22 (7.2) | 1 | 0.05 (0.01–0.22) | 0.05 (0.01–0.39) |
| Narrow-spectrum penicillinc | 19 (6.2) | 2 | 0.11 (0.03–0.31) | 0.12 (0.02–0.59) |
| Penicillins with extended spectrumd | 18 (5.9) | 3 | 0.17 (0.06–0.39) | 0.21 (0.05–0.88) |
| Macrolides | 16 (5.2) | 6 | 0.38 (0.18–0.61) | 0.75 (0.22–2.60) |
| Cephalosporins, third generation | 15 (4.9) | 2 | 0.13 (0.04–0.38) | 0.17 (0.03–0.85) |
| Metronidazole | 12 (3.9) | 2 | 0.17 (0.05–0.45) | 0.20 (0.04–1.04) |
| Aminoglycosides | 12 (3.9) | 2 | 0.17 (0.05–0.45) | 0.25 (0.05–1.34) |
| Polymyxinse | 10 (3.3) | 4 | 0.40 (0.17–0.69) | 1.00 (0.22–4.63) |
| Clindamycin | 9 (2.9) | 1 | 0.11 (0.02–0.44) | 0.13 (0.01–1.11) |
| Trimethoprim/sulfonamide | 9 (2.9) | 6 | 0.67 (0.35–0.88) | 2.00 (0.43–9.26) |
| Otherf | 13 (4.2) | 5 | 0.38 (0.18–0.64) | 0.83 (0.22–3.23) |
| Total | 307 (100) | 90 |
aEighteen prescriptions could not be assessed because of insufficient information
b OR odds ratio
cNarrow-spectrum penicillin: penicillin and flucloxacillin
dPenicillins with extended spectrum: amoxicillin and piperacillin
ePolymyxins: colistin
fOther: linezolid, nitrofurantoin, rifampicin, doxycycline, sulfadiazine
Appropriateness of antibiotic therapy by diagnosisa
| Diagnosis | Number of prescriptions (% of total) | Number of inappropriate prescriptions | Proportion of inappropriate prescriptions (95 % confidence interval) | ORb for inappropriate prescriptions (95 % confidence interval) |
|---|---|---|---|---|
| Respiratory tract infection | 94 (30.6) | 36 | 0.38 (0.29–0.48) | Reference |
| Bacteremia | 68 (22.1) | 11 | 0.16 (0.09–0.27) | 0.33 (0.15–0.72) |
| Intra-abdominal infection | 22 (7.2) | 4 | 0.18 (0.07–0.39) | 0.36 (0.11–1.16) |
| Urinary tract infection | 20 (6.5) | 9 | 0.45 (0.26–0.66) | 1.53 (0.55–4.22) |
| Skin and soft tissue infectionc | 15 (4.9) | 1 | 0.07 (0.01–0.30) | 0.13 (0.02–1.0) |
| Fever of unknown origin | 13 (4.2) | 8 | 0.69 (0.42–0.87) | 3.06 (0.86–10.90) |
| Otherd | 75 (24.4) | 21 | 0.40 (0.30–0.51) | 0.63 (0.33–1.22) |
| Total | 307 (100) | 90 |
aPer antibiotic prescription on date X, 18 prescriptions could not be assessed because of insufficient information
b OR odds ratio
cSkin and soft tissue infection: erysipelas, cellulitis, hidradenitis suppurativa, panaritium, decubitus
dOther: less than ten prescriptions per diagnosis
Appropriateness of antibiotic therapy by medical specializationa
| Medical specialization | Number of prescriptions (% of total) | Number of inappropriate prescriptions | Proportion of inappropriate prescriptions (95 % confidence interval) | ORb for inappropriate prescriptions (95 % confidence interval) |
|---|---|---|---|---|
| Lung diseases | 57 (18.6) | 16 | 0.28 (0.18–0.41) | Reference |
| Surgery | 53 (17.3) | 17 | 0.32 (0.21–0.45) | 1.25 (0.55–2.82) |
| Internal medicine | 45 (14.7) | 12 | 0.27 (0.16–0.41) | 1.03 (0.42–2.48) |
| Hematology | 25 (8.1) | 9 | 0.36 (0.20–0.55) | 0.49 (0.15–1.65) |
| Neurosurgery | 18 (5.9) | 8 | 0.44 (0.25–0.66) | 2.28 (0.75–6.94) |
| Gastroenterology/hepatology | 16 (5.2) | 6 | 0.38 (0.18–0.61) | 1.71 (0.52–5.58) |
| Neurology | 14 (4.6) | 6 | 0.43 (0.21–0.67) | 1.92 (0.58–6.42) |
| Cardiology | 14 (4.6) | 6 | 0.43 (0.21–0.67) | 2.20 (0.64–7.55) |
| Urology | 12 (3.9) | 2 | 0.17 (0.05–0.45) | 0.64 (0.12–3.35) |
| Orthopedics | 10 (3.3) | 3 | 0.30 (0.11–0.60) | 1.10 (0.25–4.78) |
| Thoracic surgery | 10 (3.3) | 2 | 0.20 (0.06–0.51) | 1.71 (0.26–11.20) |
| Otherc | 33 (10.7) | 8 | 0.24 (0.13–0.41) | 0.98 (0.36–2.65) |
a Per antibiotic prescription on date X, 18 prescriptions could not be assessed because of insufficient information
b OR odds ratio
c Other: less than ten prescriptions per medical specialization. Medical specialization in this category: ear, nose, and throat; oncology; dermatology; geriatrics; gynecology; radiotherapy